Request FREE sample PDF
Pharmacy benefit management market
BARBITURIC ACID MARKET REPORT OVERVIEW
The global barbituric acid market size was USD 20 million in 2021 and is projected to touch USD 31.08 million by 2031, exhibiting a CAGR of 4.8% during the forecast period.
Barbituric Acid is an organic compound based on a pyrimidine heterocyclic skeleton. It also goes by the name of malonylurea. Barbituric acid is an odorless powder soluble in water. It is the parent compound of barbiturate dugs. Nonetheless, barbituric acid itself is not pharmacologically active. The properties of its derivatives vary depending on the side-groups attached to it. This enables barbituric acid to be used for multiple purposes.
Barbituric acid has the potential to be developed into several drugs. The medical value of these drugs not realized until late. Barbituric acid has been proved useful as a sleeping pill. Essentially it proved effective in putting dogs to sleep. They were used in therapy of veterans who were diagnosed with Post Traumatic Stress Disorder [PTSD]. It saw a surge in usage by defense officials who used it as a ‘truth serum’ to obtain information.
COVID-19 Impact: Utility of Product as a Covid Vaccine Increased Market Share
The COVID-19 pandemic has been unprecedented and staggering, with barbituric acid market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The rise in CAGR is attributable to the barbituric acid market growth and demand returning to pre-pandemic levels once the pandemic is over.
The effects of the COVID-19 pandemic are already being felt on a global level, the global barbituric acid market was significantly influenced. The outbreak of COVID-19 had a negative impact on several markets. Various countries went into lockdown. With sudden pandemic, all kinds of businesses observed disruptions. The pandemic had a significant impact on the barbituric acid market.
There was a rapid surge in the requirement for barbituric acid. According to an article on NRC Research Press, an experiment was conducted to develop compounds to fight 2 enzymes of SARS-CoV 2. The methodology developed; generated a barbituric acid based on sulfonamides. These sulfonamides were docked with unliganded active site of SARS-CoV 2 enzymes. The concluded that ligand efficiency values against the target enzymes and DNA-lyase inhibition results of the new compounds were promising.
This led to the increased usage of barbituric acid in making of the vaccine for the novel corona virus. Furthermore, the global barbituric acid market growth saw a surge considering its usage as anesthesia. As the lockdown was imposed, the confinement of the civilization and their inability to undertake day-to-day activities caused a increased number of patients diagnosed with insomnia. An article on healthline stated that 75% of adults aged 65 and older were diagnosed with insomnia. Hence there was a increased usage of barbituric acid as a sleeping drug to help the patients fall asleep.
LATEST TRENDS
"Latest Derivatives to Boost Market Share"
The global barbituric acid market growth is expected to see a surge in usage considering recent developments in its derivatives. ScienceDirect published a journal on new barbituric acids which experimented with the ligand efficiency of various derivatives. The derivatives were named 4 and 5 and synthesized with a green and efficient protocol. The results indicated that compounds 4 and 5 possess a significant effect as reactive oxygen scavenger in comparison to standard drugs. They had better drug character likeness candidate rather than compounds.
A research paper published on PubMed Central regarding barbituric acids stated that its derivatives have ability to fight against hepatocellular carcinoma. The experiment investigated the anti-tumor effects of barbituric acid on the HCC cells. The results which were confirmed by a micro-analysis showed that BA-5 treatment influenced cancer cells motility and growth-related pathways. To conclude, barbituric acid is a new candidate for HCC and sorafenib-resistant HCC therapy.
BARBITURIC ACID MARKET SEGMENTATION
- By Type
Based on type, the market is bifurcated as follows: Pharmaceutical Grade Barbituric Acid
Industrial Grade Barbituric Acid.
The pharmaceuticals grade accounted for the largest market share.
- By Application
Based on application, the market is segmented as follows: VB2, Barbiturate, Dye Intermediates and others.
DRIVING FACTORS
"Increased Geriatric Population to Propel Growth"
The global barbituric acid market growth is expected to rise considering the increase in the geriatric population. There is increasing rate of insomnia leading to an increasing demand for sleeping medication. This is expected to drive the barbituric acid market. An article on healthline stated that 75% of adults aged 65 and older were diagnosed with insomnia . World Ageing Report of 2019 states that Japan has the world’s fastest ageing population. The report concludes that the population above the age of 65 in Japan was 35.524 million in 2019 this comprises about 28% of the population. It is projected to reach 37.278 million by 2030 comprising about 30.9% of the population. As the number of geriatric populations increases in the coming years, the growth of barbituric acid market size will expand in the forthcoming years.
"Increased Cancer Patients to Increase the Use of Barbituric Acid "
The global barbituric acid market growth is anticipated to spike owing to the increase in the number of aged people across the globe. Research published on PubMed Central had experimented barbituric acid against hepatocellular carcinoma cells. The results declared barbituric acid as a new candidate for HCC therapy. With the increasing number of old aged people, there will be a rise in several types of cancers as elderly individuals are more vulnerable. There has also been a drastic rise in the number of cancer patients. The International Agency for Research on Cancer [IRAC] updated the Globocon data of 2020 with an estimated 19.3 million cancer cases. Therefore, the rising stress of cancer cases would boost the growth of the global barbituric acid markets.
RESTRAINING FACTORS
"Addictive Nature Forms a Habit of Danger"
There are several factors that could affect the global barbituric acid market growth. Patients may develop a tolerance and habit for the barbiturates. They pose a danger as a drug as it is widely used by suicides. It also presents the problem of automatism which might cause the patient to overdose on the drug. Barbiturates and alcohol are eliminated by the same system of enzymes in the liver. If one were to consume both are a once, it might lead to liver failure or death.
BARBITURIC ACID MARKET REGIONAL INSIGHTS
"North America Leads Market Share Owing to Increasing Geriatric Population"
North America holds the largest part of the global barbituric acid market share. This is due to increasing geriatric old age population and the rising number of HCC cancer patients. The increase in the number of old aged people is a direct contributing factor to a requirement of sleep medication. Insomnia is growing issue among people aged 60 plus. As shared by SleepFoundation, almost 30% of the adults live with insomnia.
Asia Pacific holds the second-largest part of the global barbituric acid market share. This is due to increasing geriatric old age population. The increase in the number of old aged people is a direct contributing factor to a requirement of insomnia. These factors combined with the rise in the use of barbituric acid in the region contribute to the dominance of this region.
KEY INDUSTRY PLAYERS
"Market Players to Boost Market Growth"
Prominent market players are making collaborative efforts by partnering with other companies to stay ahead in the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolio.
LIST OF TOP BARBITURIC ACID COMPANIES
- Zhengzhou Lifeng Chemical [China]
- Hebei Chengxin [China]
REPORT COVERAGE
This research profiles a report with extensive studies that take into description of the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics changes.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 20 Million in 2021 |
Market Size Value By |
US$ 31.08 Million by 2031 |
Growth Rate |
CAGR of 4.8% from 2021 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Types & Application |
Frequently Asked Questions
-
What CAGR is the barbituric acid market expected to exhibit by 2031?
The barbituric acid market is expected to exhibit a CAGR of 4.8% by 2031.
-
Which are the driving factors of the barbituric acid market?
Increased geriatric population and rising number of cancer patients are drivers of this barbituric acid market.
-
Which are the top companies operating in the barbituric acid market?
Zhengzhou Lifeng Chemical and Hebei Chengxin are key companies operating in the barbituric acid market.
-
How much is the global barbituric acid market worth?
The global barbituric acid market size was USD 20 million in 2021 and is projected to touch USD 31.08 million by 2031.